Literature DB >> 16839761

SAR of biphenyl carboxamide ligands of the human melanin-concentrating hormone receptor 1 (MCH R1): discovery of antagonist SB-568849.

David R Witty1, John H Bateson, Guillaume J Hervieu, Phillip Jeffrey, Christopher N Johnson, Alison I Muir, Peter J O'Hanlon, Geoffrey Stemp, Alex J Stevens, Kevin M Thewlis, Shelagh Wilson, Kim Y Winborn.   

Abstract

We report here the discovery of a class of MCH R1 ligands based on a biphenyl carboxamide template. A docked-in model is presented indicating key interactions in the putative binding site of the receptor. Parallel high throughput synthetic techniques were utilised to allow rapid exploration of the structure-activity relationship around this template, leading to compound SB-568849 which possessed good receptor affinity and selectivity. This compound proved to be an antagonist with stability in vivo, an acceptable brain-blood ratio and oral bioavailability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839761     DOI: 10.1016/j.bmcl.2006.06.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  New insights into the binding mode of melanin concentrating hormone receptor-1 antagonists: homology modeling and explicit membrane molecular dynamics simulation study.

Authors:  Mohamed A Helal; Amar G Chittiboyina; Mitchell A Avery
Journal:  J Chem Inf Model       Date:  2011-03-03       Impact factor: 4.956

2.  Profiling the interaction mechanism of quinoline/quinazoline derivatives as MCHR1 antagonists: an in silico method.

Authors:  Mingwei Wu; Yan Li; Xinmei Fu; Jinghui Wang; Shuwei Zhang; Ling Yang
Journal:  Int J Mol Sci       Date:  2014-09-01       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.